PMID- 37203049 OWN - NLM STAT- MEDLINE DCOM- 20230522 LR - 20230803 IS - 1998-3689 (Electronic) IS - 0301-4738 (Print) IS - 0301-4738 (Linking) VI - 71 IP - 5 DP - 2023 May TI - Artificial intelligence-based stratification of demographic, ocular surface high-risk factors in progression of keratoconus. PG - 1882-1888 LID - 10.4103/IJO.IJO_2651_22 [doi] AB - PURPOSE: The purpose of this study was to identify and analyze the clinical and ocular surface risk factors influencing the progression of keratoconus (KC) using an artificial intelligence (AI) model. METHODS: This was a prospective analysis in which 450 KC patients were included. We used the random forest (RF) classifier model from our previous study (which evaluated longitudinal changes in tomographic parameters to predict "progression" and "no progression") to classify these patients. Clinical and ocular surface risk factors were determined through a questionnaire, which included presence of eye rubbing, duration of indoor activity, usage of lubricants and immunomodulator topical medications, duration of computer use, hormonal disturbances, use of hand sanitizers, immunoglobulin E (IgE), and vitamins D and B12 from blood investigations. An AI model was then built to assess whether these risk factors were linked to the future progression versus no progression of KC. The area under the curve (AUC) and other metrics were evaluated. RESULTS: The tomographic AI model classified 322 eyes as progression and 128 eyes as no progression. Also, 76% of the cases that were classified as progression (from tomographic changes) were correctly predicted as progression and 67% of cases that were classified as no progression were predicted as no progression based on clinical risk factors at the first visit. IgE had the highest information gain, followed by presence of systemic allergies, vitamin D, and eye rubbing. The clinical risk factors AI model achieved an AUC of 0.812. CONCLUSION: This study demonstrated the importance of using AI for risk stratification and profiling of patients based on clinical risk factors, which could impact the progression in KC eyes and help manage them better. FAU - Kundu, Gairik AU - Kundu G AD - Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. FAU - Shetty, Naren AU - Shetty N AD - Department of Cataract and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. FAU - Shetty, Rohit AU - Shetty R AD - Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. FAU - Khamar, Pooja AU - Khamar P AD - Department of Cataract and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. FAU - D'Souza, Sharon AU - D'Souza S AD - Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. FAU - Meda, Tulasi R AU - Meda TR AD - Department of Cataract and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India. FAU - Nuijts, Rudy M M A AU - Nuijts RMMA AD - Department of Ophthalmology, Maastricht University Medical Center, Maastricht, The Netherlands. FAU - Narasimhan, Raghav AU - Narasimhan R AD - Imaging, Biomechanics and Mathematical Modeling Solutions, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India. FAU - Roy, Abhijit Sinha AU - Roy AS AD - Imaging, Biomechanics and Mathematical Modeling Solutions, Narayana Nethralaya Foundation, Bengaluru, Karnataka, India. LA - eng PT - Journal Article PL - India TA - Indian J Ophthalmol JT - Indian journal of ophthalmology JID - 0405376 RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Humans MH - *Keratoconus/diagnosis/epidemiology MH - Cornea MH - Corneal Topography/methods MH - Artificial Intelligence MH - Risk Factors MH - Immunoglobulin E MH - Demography PMC - PMC10391495 OTO - NOTNLM OT - Artificial intelligence OT - demographics OT - keratoconus OT - progression OT - tomography COIS- None EDAT- 2023/05/19 06:42 MHDA- 2023/05/22 06:42 PMCR- 2023/05/01 CRDT- 2023/05/19 01:49 PHST- 2023/05/22 06:42 [medline] PHST- 2023/05/19 06:42 [pubmed] PHST- 2023/05/19 01:49 [entrez] PHST- 2023/05/01 00:00 [pmc-release] AID - IndianJOphthalmol_2023_71_5_1882_377010 [pii] AID - IJO-71-1882 [pii] AID - 10.4103/IJO.IJO_2651_22 [doi] PST - ppublish SO - Indian J Ophthalmol. 2023 May;71(5):1882-1888. doi: 10.4103/IJO.IJO_2651_22.